Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

[Optimal management of blood disease: keeping in sight of platelet].

Yang RC.

Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):699-700. doi: 10.3760/cma.j.issn.0253-2727.2012.09.002. Chinese. No abstract available.

PMID:
23336219
2.

A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO.

Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, Wilde JT, Williams MD; UKHCDO.

Br J Haematol. 2006 Dec;135(5):603-33. Review.

PMID:
17107346
3.

Cardiology patient page. Platelets and cardiovascular disease.

Gregg D, Goldschmidt-Clermont PJ.

Circulation. 2003 Sep 30;108(13):e88-90. No abstract available.

4.

[Method of cryopreservation of platelets at - 196 degrees C. Clinical application].

Herve P, Masse M, Potron G, Kieffer Y, Carbillet JP, Bidet A, Bosset JF, Peters A.

Rev Fr Transfus Immunohematol. 1977 Dec;20(4):603-15. French. No abstract available.

PMID:
601402
5.

Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization.

Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD.

Blood. 1993 Jun 15;81(12):3428-34.

6.

Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery.

Thaler HW, Frisee F, Korninger C.

J Trauma. 2010 Nov;69(5):1217-20; discussion 1221. doi: 10.1097/TA.0b013e3181f4ab6a.

PMID:
21068622
7.
8.

[Novel therapeutic strategy for hematological diseases using iPS cell-banking].

Eto K.

Rinsho Ketsueki. 2012 Jul;53(7):658-63. Review. Japanese. No abstract available.

PMID:
22975766
9.

Platelets and platelet inhibitors in acute myocardial infarction.

Kamat SG, Kleiman NS.

Cardiol Clin. 1995 Aug;13(3):435-47. Review.

PMID:
7585778
10.

[Survival of platelets labeled with radiochromium. Study of 104 cases].

NAJEAN Y, LARRIEU MJ, BERNARD J.

Nouv Rev Fr Hematol. 1961 Jan-Feb;1:36-54. French. No abstract available.

PMID:
13727562
11.

Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients.

Keidar S, Oiknine J, Leiba A, Shapira C, Leiba M, Aviram M.

J Cardiovasc Pharmacol. 1996 Feb;27(2):183-6.

PMID:
8720415
12.

Platelets and vascular disease.

Moser M, Bode C.

Hamostaseologie. 2009 Nov;29(4):319. No abstract available.

PMID:
19998750
13.

[Thrombocyte inhibitors in cardiovascular therapy].

L├╝scher TF, Pfisterer M.

Schweiz Rundsch Med Prax. 1990 Sep 25;79(39):1132-41. Review. German.

PMID:
2218249
15.

Anti-platelet therapy.

Smyth SS.

Curr Drug Targets. 2011 Nov;12(12):1790-1. No abstract available.

PMID:
21718241
16.

[Diet, drugs and blood platelet function].

Tamura Y, Hirai A, Terano T.

Nihon Naika Gakkai Zasshi. 1993 Jul 10;82(7):1034-9. Japanese. No abstract available.

PMID:
8228481
17.
18.
19.

[Platelet transfusions in systemic blood diseases].

Agranenko VA, Kompaniets AM, Kaveshnikova BF.

Gematol Transfuziol. 1994 Mar-Apr;39(2):32-7. Russian.

PMID:
8026687
20.

Platelets and antiplatelet therapy in patients with diabetes mellitus.

Arjomand H, Roukoz B, Surabhi SK, Cohen M.

J Invasive Cardiol. 2003 May;15(5):264-9. Review.

PMID:
12730635

Supplemental Content

Support Center